Identification of hormonal role and cardiac protection from erythropoietin in adult spontaneously hypertensive rats with doxorubicin induced cardiotoxicity
Chehab, Leena Maggie
MetadataShow full item record
Gender has been cited as a factor that may influence the degree of doxorubicin (dox) induced cardiotoxicity during chemotherapy. Younger females and adult males appear to be hypersensitive to the oxidative stress-induced cardiomyopathy. Our study examined whether gender affects the severity of dox induced toxicity in a spontaneously hypertensive rats (SHR) model. Groups of male and female SHR were subcutaneously implanted with a mammary adenocarcinoma cell line (SST-2) originally derived from a female SHR. Following implantation, they were treated with either 10 mg/kg dox, 50 mg/kg dezrazoxane (drz), 1000 mg/kg erythropoietin alpha (epo), or a combination of either drz or epo with dox. Male SHR experienced a larger decrease in weight and hematological toxicity when compared to female SHR. In addition, male cardiac function as measured by echocardiogram indicated a more pronounced decrease in overall cardiac function. Dox-induced increases in cTnT and total cardiac protein oxidation were also present to a greater extent in male SHR, in addition to a decrease in autophagy, when compared to female SHR. The addition of epo as a potential cardioprotectant attenuated dox toxicity in female SHR but did not mitigate the negative effects of dox in male SHR. A statistical analysis of cTnT levels and testosterone levels indicates a direct inverse relationship. The differences in the above parameters between male and female SHR indicates that gender influences dox-induced toxicity and testosterone may play a role in protection.
Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at firstname.lastname@example.org. Thank you.